WASHINGTON, D.C. — A dispute over the eligibility of a patent pertaining to radio frequency identification (RFID) technology under Section 101 of the Patent Act will not be considered by the U.S. Supreme Court, which denied a petition for certiorari in its May 30 order list that asked the court to consider whether subdividing serial numbers served to make an invention patent-eligible subject matter.
WASHINGTON, D.C. — Two patent infringement suits that were previously before the U.S. Supreme Court in a dispute over the appointment of administrative patent judges (APJs) by the U.S. Patent and Trademark Office (PTO) were both denied certiorari on May 22 on another appointment matter, this one pertaining to temporary appointment of government officials when a PTO position is vacant per the Federal Vacancies Reform Act (FVRA).
ALEXANDRIA, Va. — Allegations by a bank that prior art renders obvious a patent relating to a remote check deposit system and method that enables quicker access to a check’s funds have been rejected by the Patent Trial and Appeal Board.
WASHINGTON, D.C. — The Regents of the University of California have failed to persuade the Federal Circuit U.S. Court of Appeals to undo a determination by the International Trade Commission (ITC) that myriad lighting retailers do not infringe two university patents.
WASHINGTON, D.C. — A unanimous U.S. Supreme Court on May 18 affirmed trial court and circuit court rulings that two Amgen Inc. patents on anti-cholesterol antibodies are not sufficiently enabled because they seek to cover “potentially millions” of antigens that they do not claim.
ALEXANDRIA, Va. — In a preliminary patent owner response, Corrigent Corp. maintains that its patented system that determines bandwidth needs, maps logistical network topology to physical network topology and allocates the bandwidth accordingly should not be subjected to inter partes review (IPR) by the Patent Trial and Appeal Board.
WASHINGTON, D.C. — A bid by a cybersecurity company for mandamus relief from a decision by the Patent Trial and Appeal Board instituting inter partes review (IPR) of a packet-filtering patent has been turned away by the Federal Circuit U.S. Court of Appeals.
ALEXANDRIA, Va. — Litigation in Delaware federal court should take precedence over a recently filed petition for inter partes review (IPR), a patent owner tells the Patent Trial and Appeal Board, noting that trial in Delaware will occur before the board can reach a final written decision.
WASHINGTON, D.C. — Graco Inc. and its parent company urge the Federal Circuit U.S. Court of Appeals to uphold a summary judgment of noninfringement awarded to them by a federal judge in California, on grounds that a patentee’s invention for an infant soothing device is “fundamentally different” than an accused baby swing.
WASHINGTON, D.C. — A decision on rehearing by the Federal Circuit U.S. Court of Appeals that reinstated a $234 million award in favor of GlaxoSmithKline LLC (GSK) will stand in light of the U.S. Supreme Court’s May 15 denial of a generic drugmaker’s petition for writ of certiorari.
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals has joined a California federal judge in declaring pro se antitrust and patent infringement claims by a frequent litigant frivolous in a win for Apple Inc.
WASHINGTON, D.C. — In its May 15 order list, the U.S. Supreme Court announced that it will not review two cases that sought clarification on the abstract-idea exception to patent eligibility.
WASHINGTON, D.C. — A federal judge in New York did not err when declaring a computer-implemented method for processing financial transactions that involve “stored value items,” such as coupons or vouchers, ineligible for patenting, the Federal Circuit U.S. Court of Appeals has ruled.
LOS ANGELES — On remand from the Federal Circuit U.S. Court of Appeals, a federal judge in California has denied a request for summary judgment that a patented wallet with money clip is unenforceable due to inequitable conduct before the U.S. Patent and Trademark Office (PTO).
WASHINGTON, D.C. — A federal judge in Delaware did not err in declaring obvious four Vanda Pharmaceuticals Inc. patents relating to the use of tasimelteon to treat the sleep-wake disorder known as “non-24,” the Federal Circuit U.S. Court of Appeals said.
DETROIT — A bid by defendants to stay patent litigation while the Patent Trial and Appeal Board assesses their pending petition for inter partes review (IPR) has been denied by a federal judge in Michigan, who instead ordered limited discovery relating to the supply chain of electric parking brakes accused of infringement.
WASHINGTON, D.C. — A determination by the Patent Trial and Appeal Board that all claims of a data authentication patent challenged by Sony Interactive Entertainment LLC are obvious was supported by substantial evidence, the Federal Circuit U.S. Court of Appeals has ruled.
ALEXANDRIA, Va. — A patent owner on May 9 defended its at-home bodily fluid sample collection technology in a response filed with the Patent Trial and Appeal Board, arguing that a proposed combination of prior art would omit a key limitation.
WASHINGTON, D.C. — The Patent Trial and Appeal Board “failed to address” arguments by Universal Electronics Inc. (UEI) that identified a “hole” in the rejection by an examiner of an application to patent a switching device, the Federal Circuit U.S. Court of Appeals ruled May 10, vacating and remanding the board’s decision.
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on May 9 reversed a determination by the Patent Trial and Appeal Board that a patent directed to a drug delivery device is obvious over prior art.